These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 16261260)

  • 21. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.
    Scaffidi P; Misteli T
    Nat Med; 2005 Apr; 11(4):440-5. PubMed ID: 15750600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
    Yang SH; Bergo MO; Toth JI; Qiao X; Hu Y; Sandoval S; Meta M; Bendale P; Gelb MH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10291-6. PubMed ID: 16014412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
    Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
    Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S
    Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes.
    Moulson CL; Fong LG; Gardner JM; Farber EA; Go G; Passariello A; Grange DK; Young SG; Miner JH
    Hum Mutat; 2007 Sep; 28(9):882-9. PubMed ID: 17469202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulated interactions between lamin A and SUN1 induce abnormalities in the nuclear envelope and endoplasmic reticulum in progeric laminopathies.
    Chen ZJ; Wang WP; Chen YC; Wang JY; Lin WH; Tai LA; Liou GG; Yang CS; Chi YH
    J Cell Sci; 2014 Apr; 127(Pt 8):1792-804. PubMed ID: 24522183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome.
    Wang Y; Ostlund C; Worman HJ
    Nucleus; 2010; 1(5):432-9. PubMed ID: 21326826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells.
    Cao K; Graziotto JJ; Blair CD; Mazzulli JR; Erdos MR; Krainc D; Collins FS
    Sci Transl Med; 2011 Jun; 3(89):89ra58. PubMed ID: 21715679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
    Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
    J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence and distribution of progerin in HGPS cells is ameliorated by drugs that impact on the mevalonate and mTOR pathways.
    Clements CS; Bikkul MU; Ofosu W; Eskiw C; Tree D; Makarov E; Kill IR; Bridger JM
    Biogerontology; 2019 Jun; 20(3):337-358. PubMed ID: 31041622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype.
    Gabriel D; Gordon LB; Djabali K
    PLoS One; 2016; 11(12):e0168988. PubMed ID: 28033363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of nuclear F-actin formation and its relevance to cellular phenotypes in Hutchinson-Gilford progeria syndrome.
    Takahashi Y; Hiratsuka S; Machida N; Takahashi D; Matsushita J; Hozak P; Misteli T; Miyamoto K; Harata M
    Nucleus; 2020 Dec; 11(1):250-263. PubMed ID: 32954953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry.
    Camafeita E; Jorge I; Rivera-Torres J; Andrés V; Vázquez J
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards a Drosophila model of Hutchinson-Gilford progeria syndrome.
    Beard GS; Bridger JM; Kill IR; Tree DR
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1389-92. PubMed ID: 19021561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.
    Liu GH; Barkho BZ; Ruiz S; Diep D; Qu J; Yang SL; Panopoulos AD; Suzuki K; Kurian L; Walsh C; Thompson J; Boue S; Fung HL; Sancho-Martinez I; Zhang K; Yates J; Izpisua Belmonte JC
    Nature; 2011 Apr; 472(7342):221-5. PubMed ID: 21346760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging.
    Shumaker DK; Dechat T; Kohlmaier A; Adam SA; Bozovsky MR; Erdos MR; Eriksson M; Goldman AE; Khuon S; Collins FS; Jenuwein T; Goldman RD
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8703-8. PubMed ID: 16738054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin.
    Yang SH; Chang SY; Ren S; Wang Y; Andres DA; Spielmann HP; Fong LG; Young SG
    Hum Mol Genet; 2011 Feb; 20(3):436-44. PubMed ID: 21088111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterochromatin loss as a determinant of progerin-induced DNA damage in Hutchinson-Gilford Progeria.
    Chojnowski A; Ong PF; Foo MXR; Liebl D; Hor LP; Stewart CL; Dreesen O
    Aging Cell; 2020 Mar; 19(3):e13108. PubMed ID: 32087607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome.
    Goldman RD; Shumaker DK; Erdos MR; Eriksson M; Goldman AE; Gordon LB; Gruenbaum Y; Khuon S; Mendez M; Varga R; Collins FS
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8963-8. PubMed ID: 15184648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.
    Chen Z; Chang WY; Etheridge A; Strickfaden H; Jin Z; Palidwor G; Cho JH; Wang K; Kwon SY; Doré C; Raymond A; Hotta A; Ellis J; Kandel RA; Dilworth FJ; Perkins TJ; Hendzel MJ; Galas DJ; Stanford WL
    Aging Cell; 2017 Aug; 16(4):870-887. PubMed ID: 28597562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.